US Patent Issued to GB002 on Aug. 11 for "Crystalline forms of N-{3-[(1S)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-ylamino}ethylphenyl}-5-methylpyridine-3-carboxamide and related products and methods" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,693, issued on Aug. 11, was assigned to GB002 Inc. (San Diego).

"Crystalline forms of N-{3-[(1S)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-ylamino}ethylphenyl}-5-methylpyridine-3-carboxamide and related products and methods" was invented by Marcus Schestopol (San Diego), Beili Zhang (San Diego), David Paisner (San Diego), Nicole White (San Diego) and Esmir Gunic (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crystalline forms of N-{3-[(1S)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino}ethyl]-phenyl}-5-methylpyridine-3-carboxamide are provided. Pharmaceutical compositions and dosage forms containing the crystal forms are also provided, includin...